公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | E-cadherin Interacts With Posttranslationally-Modified AGO2 to Enhance miRISC Activity | Li, Jie-Ning; Sun, Hui-Lung; MING-YANG WANG ; Chen, Pai-Sheng | Frontiers in cell and developmental biology | 8 | 7 | |
2019 | Editor's Note: Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1 | Wang, Ming-Yang; Chen, Pai-Sheng; Prakash, Ekambaranellore; Hsu, Hsing-Chih; Huang, Hsin-Yi; MING-TSAN LIN ; KING-JEN CHANG ; Kuo, Min-Liang | Cancer research | 0 | 0 | |
2019 | Editor's Note: MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1α Expression and Tumor Angiogenesis | Cha, Shih-Ting; Chen, Pai-Sheng; Johansson, Gunnar; CHIA-YU CHU ; Wang, Ming-Yang; YUNG-MING JENG ; SUNG-LIANG YU ; JIN-SHING CHEN ; KING-JEN CHANG ; Jee, Shiou-Hwa; CHING-TING TAN ; MING-TSAN LIN ; Kuo, Min-Liang | Cancer research | 1 | 1 | |
2019 | Erratum: MicroRNA-519c suppresses hypoxia-inducible factor-1a expression and tumor angiogenesis (Cancer Research (2010) 70 (2675–2685) DOI: 10.1158/0008-5472.CAN-09-2448) | Cha, Shih-Ting; Chen, Pai-Sheng; Johansson, Gunnar; CHIA-YU CHU ; Wang, Ming-Yang; YUNG-MING JENG ; SUNG-LIANG YU ; JIN-SHING CHEN ; KING-JEN CHANG ; SHIOU-HWA JEE ; CHING-TING TAN ; MING-TSAN LIN ; Kuo, Min-Liang | Cancer research | 1 | 1 | |
2021 | Expression of SnoRNA U50A Is Associated with Better Prognosis and Prolonged Mitosis in Breast Cancer | Li, Jie-Ning; MING-YANG WANG ; Chen, Yi-Ting; Kuo, Yao-Lung; Chen, Pai-Sheng | Cancers | 4 | 2 | |
2022 | Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma | YU-YUN SHAO ; Chen, Pai-Sheng; LIANG-IN LIN ; Lee, Bin-Shyun; Ling, Andrew; ANN-LII CHENG ; CHIUN HSU ; DA-LIANG OU | British journal of cancer | 10 | 10 | |
2010 | MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1{alpha} Expression and Tumor Angiogenesis | CHA, SHIH-TING; CHEN, PAI-SHENG; CHU, CHIA-YU; WANG, MING-YANG; JENG, YUNG-MING; YU, SUNG-LIANG; CHEN, JIN-SHING; CHANG, KING-JEN; JEE, SHIOU-HWA; TAN, CHING-TING; LIN, MING-TSAN; KUO, MIN-LIANG; 查詩婷; 陳百昇; 朱家瑜; 王明暘; 鄭永銘; 俞松良; 陳晉興; 張金堅; 紀秀華; 譚慶鼎; 林明燦; 郭明良 | CANCER RESEARCH | | | |
2022 | TARBP2 Suppresses Ubiquitin-Proteasomal Degradation of HIF-1α in Breast Cancer | Li, Jie-Ning; Chen, Pai-Sheng; Chiu, Ching-Feng; Lyu, Yu-Jhen; Chiao Lo ; LI-WEI TSAI ; Wang, Ming-Yang | International journal of molecular sciences | 6 | 5 | |
2019 | TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer | Wang, Ming-Yang; Huang, Hsin-Yi; Kuo, Yao-Lung; Chiao Lo ; Sun, Hung-Yu; Lyu, Yu-Jhen; Chen, Bo-Rong; Li, Jie-Ning; Chen, Pai-Sheng | Cancers | 8 | 7 | |
2019 | TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma | Lai, Hui-Huang; Li, Chih-Wei; Hong, Chih-Chen; Sun, Hung-Yu; Chiu, Ching-Feng; DA-LIANG OU ; Chen, Pai-Sheng | Molecular oncology | 23 | 22 | |